Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

66 evidences · page 2 / 3

0,5 %The prevalence of HCV infection was 0.5% among HIV-naïve children in Lagos.

Nigeriahépatite C · VIH/sidapublié 2020PloS onePubMeddocument de 4 observations

0,8 %Hepatitis C seropositivity was observed in 10 (0.8%) of 1329 patients enrolled for haemodialysis between 2019 and 2022 in four public dialysis centres in Kano and Jigawa state, Northwest Nigeria.

Nigeriahépatite Cobservé 2019–2022publié 2023The Nigerian postgraduate medical journalPubMeddocument de 10 observations

0,14 %Among 2775 pregnant women in Nigeria, the seroprevalence of triplex infection with HIV, HBV, and HCV was 0.14%.

Nigeriahépatite B · hépatite C · VIH/sidapublié 2025Antiviral therapyPubMeddocument de 7 observations

100 US$Commodity costs for hepatitis C virus diagnostics fell from over US$100 per diagnostic test.

Nigeriahépatite Cpublié 2020BMJ global healthPubMeddocument de 6 observations

1,3 %Hepatitis C virus seroprevalence among pregnant women in Nigeria was 1.3%.

Nigeriahépatite Cpublié 2021Women's health (London, England)PubMeddocument de 7 observations

14,6 %The prevalence of Hepatitis C co-infection among people living with HIV/AIDS in a rural Northern Nigerian community was 14.6%.

Nigeriahépatite C · VIH/sidapublié 2020The Pan African medical journalPubMeddocument de 4 observations

2,6 %The prevalence of hepatitis C virus (HCV) among patients attending public hospitals in Lagos, Nigeria was 2.6%.

Nigeriahépatite Cpublié 2025The Nigerian postgraduate medical journalPubMeddocument de 7 observations

0,47 %Among 2775 pregnant women in Nigeria, the seroprevalence of dual infection with HIV, HBV, and HCV was 0.47%.

Nigeriahépatite B · hépatite C · VIH/sidapublié 2025Antiviral therapyPubMeddocument de 7 observations

2 300 000 peopleGlobally, approximately 2.3 million people living with HIV are co-infected with hepatitis C virus.

Nigeriahépatite C · VIH/sidapublié 2024Journal of infection in developing countriesPubMeddocument de 5 observations

0,64 %The prevalence of HIV/HBV/HCV triple co-infection among HIV-positive patients attending three major hospitals in the Federal Capital Territory, Nigeria was 0.64%.

Nigeriahépatite B · hépatite C · VIH/sidaobservé 2019publié 2020Journal of immunoassay & immunochemistryPubMeddocument de 9 observations

0 %The mother-to-child transmission (MTCT) rate for HIV, HBV, and HCV among pregnant women in Nigeria was 0% at 6-week post-delivery.

Nigeriahépatite B · hépatite C · VIH/sidaobservé 6-week post-deliverypublié 2025Antiviral therapyPubMeddocument de 7 observations

0,6 %Dual seropositivity of anti-hepatitis C virus/anti-HIV among pregnant women in Nigeria accounted for 0.6%.

Nigeriahépatite C · VIH/sidapublié 2021Women's health (London, England)PubMeddocument de 7 observations

4,8 %Hepatitis C virus (HCV) prevalence was 4.8% among 248 patients at the Federal Medical Center, Makurdi.

Nigeriahépatite Cpublié 2024BMC public healthPubMeddocument de 7 observations

0,5 %The prevalence of HCV infection was 0.5% among HIV-infected children in Lagos.

Nigeriahépatite C · VIH/sidapublié 2020PloS onePubMeddocument de 4 observations

0 casesNone of the 204 HIV-infected children and young adults tested in Calabar, Nigeria were positive for HCV antibody.

Nigeriahépatite Cpublié 2024Journal of infection in developing countriesPubMeddocument de 5 observations

0,3 %The hepatitis C prevalence in non-conflict zones in Nigeria was 0.3%.

Nigeriahépatite Cobservé 2018publié 2021Annals of global healthPubMeddocument de 12 observations

4,1 %Among all donors tested for transfusion transmissible infections, 358 (4.1%) tested positive for Hepatitis C.

Nigeriahépatite Cobservé 2020-2022publié 2025BMC infectious diseasesPubMeddocument de 17 observations

0,218 pearson_correlation_coefficientA positive correlation was found between age and HCV prevalence (Pearson Correlation = 0.218, p < 0.001).

Nigeriahépatite Cpublié 2025Journal of health, population, and nutritionPubMeddocument de 5 observations

90 %The hepatitis C virus cure (SVR12) rate was greater than 90%, including at lower-tier facilities.

Nigeriahépatite Cpublié 2020BMJ global healthPubMeddocument de 6 observations

4,5 %Hepatitis C infection was observed in 4.5% of the children.

Nigeriadrépanocytose · hépatite Cpublié 2021West African journal of medicinePubMeddocument de 10 observations

2 209 209 patientsAs of December 2019, 2,209,209 patients were screened for hepatitis C virus.

Nigeriahépatite Cobservé December 2019publié 2020BMJ global healthPubMeddocument de 6 observations

4,9 %Among 265 livestock handlers in Ibadan, Nigeria, 13 (4.9%) tested positive for HCV infection.

Nigeriahépatite Cobservé October 2016 to April 2017publié 2024African health sciencesPubMeddocument de 5 observations

15,7 %The most identified risk factor for hepatitis C virus infection among pregnant women in Nigeria was multiple sexual partners, reported by 15.7% of participants.

Nigeriahépatite Cpublié 2021Women's health (London, England)PubMeddocument de 7 observations

1 casesOne (1.1%) participant was positive for anti-HCV.

Nigeriahépatite Cpublié 2020Journal of immunoassay & immunochemistryPubMeddocument de 8 observations

HCV co-infection had no effect on AIDS status at baseline among treatment-naïve adult HIV-infected patients.

Nigeriahépatite C · VIH/sidapublié 2021Annals of African medicinePubMeddocument de 3 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.